Takeda, Sanofi Team Up To Explore DPP-4 Market In China
This article was originally published in The Pink Sheet Daily
Executive Summary
Takeda will partner with Sanofi to co-promote its DPP-4 inhibitor Nesina, which is expected to be approved in China this year.